Dimerix Ltd
DXB
Company Profile
Business description
Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
Contact
425 Smith Street
Fitzroy VIC 3065
AUST: +61 1300813321
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
9
Stocks News & Analysis
stocks
Undervalued bank reports earnings
Shares jump but the operating environment remains difficult and we lower our fair value.
video
Impact of the supermarkets code of conduct
Morningstar Director of Equity Research Johannes Faul explains the impact of the political hot water that Coles and Woolworths face.
stocks
Four cheap wide moat ASX stocks
We follow Buffett’s adage to find great companies trading at attractive prices.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,892.10 | 31.10 | 0.40% |
| CAC 40 | 7,981.51 | 48.90 | 0.62% |
| DAX 40 | 17,770.02 | 3.79 | 0.02% |
| Dow JONES (US) | 37,753.31 | 45.66 | -0.12% |
| FTSE 100 | 7,847.99 | 27.63 | 0.35% |
| HKSE | 16,251.84 | 2.87 | 0.02% |
| NASDAQ | 15,683.37 | 181.88 | -1.15% |
| Nikkei 225 | 37,647.68 | 314.12 | -0.83% |
| NZX 50 Index | 11,799.54 | 75.81 | -0.64% |
| S&P 500 | 5,022.21 | 29.20 | -0.58% |
| S&P/ASX 200 | 7,635.30 | 29.70 | 0.39% |
| SSE Composite Index | 3,071.38 | 64.31 | 2.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.86% |
| Pantoro Ltd PNR | 0.08 | 0.00 | 1.83% |
| Renascor Resources Ltd RNU | 0.11 | 0.01 | 7.14% |
| Pilbara Minerals Ltd PLS | 3.88 | 0.04 | 1.04% |
| Telstra Group Ltd TLS | 3.68 | 0.01 | -0.14% |
| Evolution Mining Ltd EVN | 4.00 | 0.17 | -3.97% |
| Bellevue Gold Ltd BGL | 1.83 | 0.08 | -3.94% |
| Mesoblast Ltd MSB | 0.77 | 0.02 | 2.33% |
| Imugene Ltd IMU | 0.08 | 0.00 | 1.20% |
| The Star Entertainment Group Ltd SGR | 0.42 | 0.00 | 0.00% |